NEUROSCIENCE TECHNOLOGIES is a biomedical company with expertise in human pain neurophysiology. We help the pharmaceutical and biotechnology industries in assessing their new pain drugs.
We use microneurography to quantify spontaneous activity in pain fibers, both in patients and in human and animal models of painful conditions. This objective biomarker of spontaneous pain provides the most direct test of the efficacy of new compounds, which can be applied to pain models and then translated with confidence to the clinical setting.